RecovryAI

Rule Changes

Conducting pivotal clinical study; preparing FDA submission

In August 2026, the FDA's device center published a discussion paper on how to regulate generative AI medical devices and asked for public comment. The paper is the agency's most concrete step toward formal rules for a technology it has never authorized in a commercial device.

Updated Oct 17